[MYGN] YoY Quarter Result on 31-Mar-2016 [#Q1]

Stock
[MYGN] Myriad Genetics, Inc.
Announcement Date
04-May-2016
Financial Year
2016
Quarter
31-Mar-2016 [#Q1]
Profit Trend
QoQ- 7.59%
YoY- 51.80%
Quarter Report
MYGN's Result
MYGN's Financial Summary
View:
Show?
Quarter Result
31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 CAGR
Revenue 216,600 193,500 196,900 190,500 179,985 182,924 156,472 5.56%
PBT 3,300 16,500 8,000 43,100 35,566 57,343 59,241 -38.18%
Tax -3,600 5,200 3,800 10,500 14,091 20,573 21,349 -
NP 6,900 11,400 4,200 32,600 21,475 36,770 37,892 -24.70%
Tax Rate 109.09% -31.52% -47.50% -24.36% -39.62% -35.88% -36.04% -
Total Cost 209,700 182,100 192,700 157,900 158,510 146,154 118,580 9.96%
Ratio Analysis
31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 CAGR
NP Margin 3.19 5.89 2.13 17.11 11.93 20.10 24.22 -28.65%
Per Share
31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 CAGR
EPS 0.09 0.16 0.06 0.49 0.30 0.50 0.47 -24.07%
EPS Diluted 0.09 0.16 0.06 0.47 0.29 0.48 0.46 -23.79%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.